Scaling Up Gene Therapy Manufacturing: Strategies to Overcome Capacity Challenges
As vector-delivered advanced therapies inch towards commercialization, a significant bottleneck has emerged: experienced manufacturing capacity.
Blog
Plasmid Power: Navigating Challenges with Precision and Quality in Advanced Therapy Development
When developing advanced therapies, the significance of plasmids cannot be overstated. These genetic building blocks form the backbone of cell and gene therapies
The Future of Advanced Therapy Delivery: Insights from Industry Experts
The realm of advanced therapies is on the cusp of an evolution, driven by the need to overcome the challenges that come with the success of adeno-associated vector (AAV)-based therapies.
Navigating Preclinical Manufacturing: Paving the Path to Clinical Success
Cell and gene therapy has tremendous potential, yet the journey from discovery to clinical success is a multifaceted endeavor.
Scaling Allogeneic Cell Therapy Manufacturing
A contract development and manufacturing organization (CDMO) is an outsourcing agency for pharmaceutical and life sciences industries specializing in the precise and delicate process of creating and bulk-producing life-changing and lifesaving drugs.
Scaling Up Gene Therapy Manufacturing
Scaling up gene therapy manufacturing involves increasing production capacity while maintaining the quality and consistency of the product.
Lentiviral Vector Manufacturing and Distribution
Gene and cell therapy medicines, in particular those delivered via lentiviruses, are poised to be the future of disease treatment.
What Should Companies Look For When Selecting a CDMO For Process Development (PD)
The best PD offerings are integrated services over the entire therapeutic development cycle--from initial development to commercialization.
The Importance of High-Quality Precision Plasmids for Cell and Gene Therapies
A contract development and manufacturing organization (CDMO) is an outsourcing agency for pharmaceutical and life sciences industries specializing in the precise and delicate process of creating and bulk-producing life-changing and lifesaving drugs.
De-Risking C> Therapies Early In Process Development
De-risking C> therapies early in process development is critical to ensuring patient safety and maximizing the therapy's potential benefits.
CAR T Testing Strategies
CAR T-cell therapy is an innovative approach to treating cancer that involves engineering a patient's T cells to recognize and attack cancer cells. However, developing a CAR T testing strategy can be a complex process that requires careful consideration of many factors.
Plasmid DNA Manufacturing for Cell and Gene Therapies
>Plasmid DNA manufacturing is the process of producing plasmid DNA in large quantities for use in research, diagnostics, and therapeutics.
What is Cell Therapy Manufacturing
Cell therapy manufacturing is the process of creating therapeutic products using living cells, tissues, or organs to treat a variety of diseases and medical conditions.
First-time Right Approach to Advanced Therapy Process Development
A first-time-right approach to cell and gene therapy process development involves designing and executing the process in a way that ensures the highest likelihood of success on the first attempt.
Cell Banking with CDMOs
Cell bank manufacturing and release services must prioritize the most stringent safety requirements and aim to optimize cell line longevity over the life of your biopharmaceutical.
What is Viral Vector Manufacturing
Viral vector manufacturing is the process of producing viral vectors, which are viruses that have been modified to deliver specific genetic material to a cell.